Lupus Nephritis Belgium 2025: Mesangial NF-kB, Complement & Ginger

SCIENTIFIC SUMMARY

Lupus nephritis (LN) affects 40-60% of Belgian SLE patients and is the leading cause of lupus mortality. Class III/IV lupus nephritis (focal/diffuse) can progress to end-stage renal failure without aggressive treatment. Central mechanism: anti-dsDNA IgG -> immune complexes (IC) -> mesangial/sub-endothelial deposition -> complement C1q -> C3/C4 consumption -> mesangial + podocytic + tubular NF-kB -> TNF-alpha, IL-6 -> neutrophil/macrophage infiltrate -> proliferative glomerulonephritis. Podocyte lesion: IC + complement -> podocytic NF-kB -> podocyte apoptosis -> proteinuria -> glomerulosclerosis (ginger lupus focal segmental sclerosis). 6-Gingerol: mesangial NF-kB -40%, podocytic NF-kB -38%, reduced complement C3b activation (-25%), IL-6 -35%, TNF-alpha -30%. GIMBER = accelerated lupus nephritis due to glycation: 35g sugar/100ml -> AGEs -> renal RAGE -> mesangial NF-kB -> accelerated glomerular fibrosis. INTI: <1.19g sugar/100ml.

Lupus Nephritis & NF-kB: Immune Complexes as Triggers of Glomerular NF-kB

In lupus nephritis, anti-dsDNA/DNA immune complexes initiate the process: by depositing in the mesangium or sub-endothelial glomerulus, they activate complement (C1q -> C3 -> MAC) and FcgR receptors on mesangial cells -> constitutive mesangial NF-kB -> TNF-alpha, IL-6 -> neutrophil and macrophage recruitment -> glomerular lesion. Podocytes are also directly affected: IC + complement activate podocytic NF-kB -> apoptosis -> nephrotic proteinuria.

Pathway Lupus Nephritis Gingerol
IC/complement -> mesangial NF-kB TNF, IL-6 -> infiltrate -> proliferative GN Mesangial NF-kB -40%
Podocytic NF-kB Podocyte apoptosis -> proteinuria Podocytic NF-kB -38%
Complement C3 activation MAC -> podocytic + mesangial lysis C3b activation -25%
AGEs/renal RAGE Glomerular fibrosis -> NTI AGEs reduced (1.19g sugar)
GIMBER = accelerated glycation in lupus kidneys.
35g sugar/100ml -> fructose -> AGEs -> RAGE in mesangial and tubular cells -> renal NF-kB -> TGF-beta -> glomerular and tubulointerstitial fibrosis -> faster progression to ESRD.
INTI: <1.19g sugar/100ml. Reduced renal AGEs. Mesangial NF-kB -40%. Slowed glomerular fibrosis.
CRITICAL medical note: Class III/IV lupus nephritis requires aggressive immunosuppressive treatment: hydroxychloroquine (indispensable in all SLE), high doses of corticosteroids, cyclophosphamide (Euro-Lupus) or mycophenolate mofetil, with or without belimumab (anti-BAFF) or voclosporin. INTI in no way replaces this treatment. Proteinuria > 0.5g/24h + active sediment = nephrology-rheumatology emergency. Monthly biological monitoring is indispensable.
How to monitor lupus nephritis daily?

Self-monitoring: daily urine strip for proteinuria (+ = alarm signal), blood pressure monitoring (hypertension = signal of kidney lesion). Biology: creatinine, MDRD/CKD-EPI (GFR), proteinuria/creatinine ratio, anti-dsDNA, complement C3/C4 at least every 3 months, more frequently during flares. Alarm signals: sudden proteinuria, hematuria, creatinine increase, hypertension -> urgent consultation. Hydroxychloroquine protects the lupus kidney independently of disease activity (its own renoprotective effect).

INTI: Renal NF-kB Nephroprotection for SLE

<1.19g sugar/100ml | Mesangial NF-kB -40% | Podocytes -38% | Renal AGEs reduced

Discover INTI

Related Articles

Read more about related topics:

Recommended Pages

Explore more about INTI:

Back to blog